Benzinga

Benzinga

Benzinga

giovedì, settembre 03

bioAffinity Technologies Inc

BIAFNASDAQ
Trade with Public
Trade with Public
$9.75
3.1647.95%
In chiusura: Sep 1, 5:00 PM EST
$12.85
6.2694.99%
Pre-mercato: 8:17 AM EST
PanoramicaNotiziePrevisioni utiliObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaRapporto azionario

bioAffinity Technologies Analyst Price Targets

Wall Street analyst price targets and consensus rating for bioAffinity Technologies (BIAF).

Price Target Range —

Analyst Consensus — 1 Analysts

1Hold
# Analysts1

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Apr 1, 2025Maxim GroupAnthony VendettiDowngradeBuy→Hold—
Jul 23, 2024Maxim GroupAnthony VendettiInitiateBuy$6

Analyst Ratings News

PRO
Maxim Group Downgrades bioAffinity Technologies to Hold

Maxim Group analyst Anthony Vendetti downgrades bioAffinity Technologies (NASDAQ:BIAF) from Buy to Hold.
Benzinga Newsdesk

US Stocks Likely To Open Mixed After Disappointing Q1 Performance: 'April Does Better After A Weak Q1,' Says Expert

U.S. stock futures were swinging between gains and losses on Tuesday after a mixed session on Monday. Futures of major benchmark indices were mixed in premarket trading. President Donald Trump‘s “Liberation Day”, the term he’s used for April 2nd, the day of incoming reciprocal tariffs, preceded a drop in stock prices.
Rishabh Mishra

PRO
Maxim Group Initiates Coverage On bioAffinity Technologies with Buy Rating, Announces Price Target of $6

Maxim Group analyst Anthony Vendetti initiates coverage on bioAffinity Technologies (NASDAQ:BIAF) with a Buy rating and announces Price Target of $6.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved